What is DexCom's cash & equivalents?

DexCom (DXCM) reported cash & equivalents of $1.12B in Q1 2026.

How has DexCom's cash & equivalents changed year-over-year?

DexCom's cash & equivalents increased by 23.4% year-over-year, from $906.1M to $1.12B.

What is the long-term trend for DexCom's cash & equivalents?

Over 5 years (2020 to 2025), DexCom's cash & equivalents has grown at a 2.4% compound annual growth rate (CAGR), from $818.2M to $919.1M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

DexCom DXCM Cash & Equivalents

Cash & Equivalents at other companies

Travel + LeisureTNL

$456M+24.3%

Warrior Met CoalHCC

$210.55M-54.5%

Main Street CapitalMAIN

$20.79M-81.0%

Cabot CorporationCBT

$252M+18.3%

HES

Hess MidstreamHESM

$4.6M-24.6%

SOL

SOLSSOLS

$642M-3.9%

Other financials

Income statement

See full

Revenue$1.2B+15.0%

Gross profit$750.3M+27.4%

Operating income$255.3M+90.9%

Net income$199.5M+89.3%

EPS (diluted)$0.51+88.9%

Balance sheet

See full

Total debt$143.0M+2.2%

Total equity$3.0B+30.5%

Total assets$6.6B-1.8%

Cash flow

See full

Operating cash flow$525.6M+186%

CapEx$76.6M-12.0%

Free cash flow$449.0M+364%

Valuation

See full

Market cap$25.99B-17.5%

Enterprise value$25.01B-17.9%

P/E27.9×-27.2×

P/S5.4×-1.9×

Profitability

See full

Gross margin61.5%+2.1pp

Operating margin21.4%+6.2pp

Net margin19.3%+6.4pp

FCF margin29.7%+15.8pp

Returns & leverage

See full

Return on equity35.6%+11.9pp

Debt / equity0×0.0×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by DexCom in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: DexCom’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about DexCom's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DexCom's cash & equivalents?: DexCom (DXCM) reported cash & equivalents of $1.12B in Q1 2026.
How has DexCom's cash & equivalents changed year-over-year?: DexCom's cash & equivalents increased by 23.4% year-over-year, from $906.1M to $1.12B.
What is the long-term trend for DexCom's cash & equivalents?: Over 5 years (2020 to 2025), DexCom's cash & equivalents has grown at a 2.4% compound annual growth rate (CAGR), from $818.2M to $919.1M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.